Nurix Therapeutics Presents Positive Results from the Ongoing Clinical Trial of Its BTK Degrader NX-5948 in Patients with Relapsed/Refractory Waldenstrom’s Macroglobulinemia
NX-5948 demonstrated robust clinical activity with objective responses observed in 7 of 9 (77.8%) evaluable Waldenstrom’s patients in the ongoing Phase 1a/1b clinical trial Responses are durable and deepen over…
Valour, la filiale de DeFi Technologies, renforce sa stratégie sur le marché nordique avec le transfert de ses ETP cryptographiques vers le marché boursier Spotlight
Mouvement stratégique sur le marché nordique : Valour Inc., une filiale de DeFi Technologies, va transférer 19 de ses ETP du marché nordique de croissance vers le marché boursier Spotlight…
Valour, Tochtergesellschaft von DeFi Technologies, stärkt ihre Strategie für den nordischen Markt mit der Übertragung von Krypto-ETPs an die Spotlight-Börse
Strategischer Schritt auf dem nordischen Markt: Valour Inc., eine Tochtergesellschaft von DeFi Technologies, wird 19 ihrer ETPs vom Nordic Growth Market an den Spotlight Stock Market in Stockholm übertragen, um…
Harbourfront annonce l’acquisition d’un courtier de l’OCRI de 1,2 milliard de dollars
VANCOUVER, Colombie-Britannique, 18 oct. 2024 (GLOBE NEWSWIRE) -- Le Groupe Harbourfront (« Harbourfront ») a annoncé aujourd’hui l’acquisition de Rothenberg Gestion de Patrimoine (« Rothenberg »). Cette transaction inclut un courtier en valeurs mobilières…
Loyalty Management Market to Reach USD 21.28 Billion by 2031
Westford,USA, Oct. 18, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Loyalty Management Market will reach a value of USD 21.28 Billion by 2031, with a CAGR of 10.5% during…
Oleochemicals Market to Reach $54.43 Billion by 2031
Westford, US, Oct. 18, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the global oleochemicals market size will reach a value of USD 54.43 Billion by 2031, with a CAGR of…
DBV Technologies to Participate in Upcoming ACAAI 2024 Congress
Châtillon, France, October 18, 2024 DBV Technologies to Participate in Upcoming ACAAI 2024 Congress DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company,…
Cloud ERP Market to Witness 12.6% CAGR by 2031
Westford,USA, Oct. 18, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that Cloud ERP Market will attain the value of USD 186.57 billion by 2031, with a CAGR of 12.6% during the…
DBV Technologies participera au prochain congrès de l’ACAAI 2024
Châtillon, France, le 18 octobre (22 :30 CEST) 2024 DBV Technologies participera au prochain congrès de l'ACAAI 2024 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock…
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DURHAM, N.C., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on October 16, 2024, the Compensation Committee of Chimerix’s Board of Directors granted an inducement award to…